Clinical trial
Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)
NCT04828863 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 12, 2021
- Completion date
- November 30, 2023
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.